TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T95289	Retinoic acid receptor RXR beta	B1M8DA	(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-3-[1,2,4]triazol-4-yl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid	Investigative	10292425	C22H29N3O2	367.5	CC1=C(C(CCC1N2C=NN=C2)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	IC50 = 250000 nM	Non binder
T95289	Retinoic acid receptor RXR alpha	B1M8DA	(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-3-[1,2,4]triazol-4-yl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid	Investigative	10292425	C22H29N3O2	367.5	CC1=C(C(CCC1N2C=NN=C2)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	IC50 = 410000 nM	Non binder
T95289	Retinoic acid receptor RXR beta	B1QOX6	N-(1H-Imidazole-1-yl)-(E)-retinamide	Investigative	11382535	C23H30N2O	350.5	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)N2C=CN=C2)/C)/C	IC50 = 500000 nM	Non binder
T95289	Retinoic acid receptor RXR alpha	B1QOX6	N-(1H-Imidazole-1-yl)-(E)-retinamide	Investigative	11382535	C23H30N2O	350.5	CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)N2C=CN=C2)/C)/C	IC50 > 1000000 nM	Non binder
T95289	Retinoic acid receptor RXR gamma	B3WGC2	6-(3-((S)-1-Methoxypropan-2-yloxy)-5-((S)-1-phenylpropan-2-yloxy)benzamido)nicotinic acid	Investigative	11340230	C26H28N2O6	464.5	C[C@@H](CC1=CC=CC=C1)OC2=CC(=CC(=C2)C(=O)NC3=NC=C(C=C3)C(=O)O)O[C@@H](C)COC	IC50 > 1000000 nM	Non binder
T95289	Retinoic acid receptor RXR beta	BGJ82Y	(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-3-[1,2,4]triazol-1-yl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid	Investigative	9885573	C22H29N3O2	367.5	CC1=C(C(CCC1N2C=NC=N2)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	IC50 = 1000000 nM	Non binder
T95289	Retinoic acid receptor RXR alpha	BGJ82Y	(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-3-[1,2,4]triazol-1-yl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid	Investigative	9885573	C22H29N3O2	367.5	CC1=C(C(CCC1N2C=NC=N2)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C	IC50 > 1000000 nM	Non binder